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Objective: Primary papillary serous carcinoma (PPSC) of the cervix is rarely recognized, with the aggressive and
unpredictable course. Here we report a case of primary adenosquamous papillary serous carcinoma of the cervix
in a woman who underwent comprehensive treatment.
Case: A 53-year-oldwoman presentedwith irregular vaginal bleeding in hospital. The patient with a diagnosis of
PPSC by an intracolposcopic biopsy received radical hysterectomy with bilateral salpingo-oophorectomy, right
pelvic lymphadenectomy, left pelvic lymph node dissection, and postoperative concurrent chemoradiotherapy.
Postoperative immunohistochemistry showed that CK5/6, CK7, P16, CEA, CA12-5 and P53 were positive. During
17 months after operation, the patient demonstrated distant metastases of lymph nodes and ﬁnally died of brain
metastasis.
Conclusions: Papillary serous adenocarcinoma of the cervix mixed with squamous cell carcinoma has not been
reported since now, and here, this is the ﬁrst documented case. Despite surgery and concurrent chemoradiother-
apy, which were reported as effective therapeutic strategies for papillary serous adenocarcinoma of the cervix,
the patient showed a poorer prognosis. Taken together, papillary serous adenosquamous carcinoma of the cervix
could be more malignant than pure papillary serous adenocarcinoma.© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Papillary serous carcinomas (PSCs), which are frequently found in
the ovarian, fallopian tube, endometrium and peritoneum, rarely arise
in the cervix. To our knowledge, there have been no more than 50
cases since now (Lurie et al., 1991; Power et al., 2008; Ueda et al.,
2012). Carcinomas with a mixture of malignant glandular and squa-
mous cell components are known as adenosquamous carcinomas that
are uncommon in the cervix. Although adenosquamous carcinomas do
not grossly differ from adenocarcinomas, this is the ﬁrst documented
case of papillary serous adenocarcinoma mixed with squamous cells in
the endocervix and the optimal treatment is still unknown.We reporteda; CEA, carcinoembryonic anti-
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uterine cervix.
Case report
A 53-year-old G2P1 woman with a history of irregular vaginal
bleeding for 6 months, presented to our hospital. Ultrasonography and
colposcopy revealed a 2.6 × 2.1 cm in diameter lesion with the obscure
boundary in the cervix. A biopsy of the cervicalmass identiﬁed a diagno-
sis of squamous cell carcinoma (SCC). The cancer antigen (CA) 12-5was
3460 U/ml (normal b35 U/ml) and the carcinoembryonic antigen
(CEA) 75.23 ng/ml (normal b 5 ng/ml). Magnetic resonance imaging
(MRI) showed an enlarged uterine cervical mass and the swelling of
multiple lymph nodes in her retroperitoneum and pelvis. Furthermeta-
static examination including computed tomography (CT) scan of head
and chest, electronic colonoscopy, and epigastrium ultrasonography
did not show any metastases in other organs. The tumor was classiﬁed
as International Federation of Gynecology and Obstetrics (FIGO) stage
IIa SCC.
Radical hysterectomy with bilateral salpingo-oophorectomy and left
pelvic nodedissection and right pelvic lymphadenectomywasperformed.
Intraoperatively, the uterus was a little hypertrophy and several swelling
lymph nodeswere observed inside the pelvis, and a rapid biopsy ofwhich
Fig. 1. Papillary serous adenosquamous carcinoma of the cervix. A)Histological section demonstrates the nuclear pleomorphism (H&E × 100). B) Atypical pleomorphic nuclei are positive
for CA12-5 (original × 200). C) Atypical cells are positive for CEA (original × 200). D) Atypical pleomorphic nuclei are positive for CK7 (original × 200). E)Malignant cells are positive for
P16 (original × 200). F) Atypical cells are positive for P53 (original × 200).
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appearance. The resected mass was a hard and swollen tumor on the
posterior wall of the cervix, which was 4 × 3 cm in diameter. All the
specimens were used for histopathological examination. The tumor was
deﬁned as adenosquamous carcinoma (ASC) and most part of it was
papillary serous carcinoma (PSC). In addition, the tumor had involved
itself in right fallopian tube, bilateral ovary, pelvic lymph nodes, and the
full thickness of the cervix without involvement of the outer membrane,
but not in the inferior vagina. Immunohistochemistry (IHC) showed
strong positivity for CK5/6, CK7, P16, CEA and CA12-5, intermediate for
P53 but negativity for CK20.
In view of the intraoperative observation indicating that the tumor
was in late stage, the patient was determined to receive concurrent
chemoradiotherapy with paclitaxel and carboplatin. Due to severe
myelosuppression, the patient received only four cycles of chemothera-
py and one timeof radiation, afterwhichCA12-5 fell to 682.30 U/ml and
CEA 12.14 ng/ml as described previously (Zhou et al., 1998). Two
months later, a 1.4 cm enlarged lymph node was observed in the left
posterior triangle of the neck by CT scan. Furthermore, a biopsy of this
lymph node showed metastatic squamous cell carcinoma. The second
radiotherapy was performed on her left neck at 54 Gy. After that,
the lymph node diminished. The patient also received ﬁve cycles of
cisplatin and three additional cycles of gemcitabine/cisplatin. However,the patient's condition deteriorated with the observation of intracranial
metastasis and she died in October 2012.
Discussion
Adenosquamous carcinoma (ASC) of the cervix is a relatively
uncommon histological subtype of cervical cancer. The squamous cell
component is poorly differentiated and shows little keratinization.
Histologically, the tumor is characterized by nests and cords of small
oval cells with a peripheral palisading arrangement. It has been reported
that adenosquamous carcinoma of the cervix has a poorer prognosis
than pure adenocarcinoma or squamous cell carcinoma (Longatto-Filho
et al., 2009; Huang et al., 2012).
Primary serous carcinoma of the cervix (PSCC) is uncommon, recently
described as one subtype of cervical adenocarcinoma (Young and Scully,
1990; Gilks and Clement, 1992). Only approximately 47 cases have been
reported, many of which had pelvic and retroperitoneal lymph node
metastases on diagnosis regardless of the clinical stage (Lurie et al.,
1991; Power et al., 2008; Ueda et al., 2012). A few studies reported
mixed papillary serous carcinoma containing endometrioid adenocarci-
noma, clear cell adenocarcinoma or well-differentiated villoglandular
adenocarcinoma, but not with squamous cell carcinoma (Zhou et al.,
1998). Here we reported a case with regard to PSCC mixed with SCC.
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metastatic sites include surgery, postoperative chemotherapy and radio-
therapy, or concurrent chemoradiotherapy (Cherry and Glucksmann,
1956). Radical hysterectomy has long been performed to the patients
with the tumors from FIGO stages I to IIa in our hospital, whereas radia-
tion treatment can be used for all stages. Papillary serous carcinomas
can also arise in ovary, fallopian tube, endometrium and peritoneum. It
is noteworthy that the cervical PSC was histologically similar to the peri-
toneal and ovarian carcinomas (Ueda et al., 2012). In this case, using
ultrasonography, CT and MRI scans, we did not ﬁnd ovarian lesions,
omental cakes or tubal masses; this tumor was ﬁnally diagnosed to
have originated from the cervix and classiﬁed as FIGO stage IIa. How-
ever, during the operation, abnormal mass was also observed
in fallopian tube and ovary, postoperative biopsy of which demon-
strated adenosquamous carcinoma that could not preclude a diagno-
sis of original cancer of fallopian tube or ovary (Terada, 2009). In
view of intraoperative observation, radical hysterectomy with bilat-
eral salpingo-oophorectomy and removal of right pelvic lymph
nodes was performed in this case. In order to improve survival, post-
operative chemoradiotherapy was performed even though there was
still a controversy on the beneﬁt of chemotherapy or pelvic radiation
therapy to improve survival of patients with different stages of ASC
(Huang et al., 2012; Peters et al., 2000; Monk et al., 2005; Sedlis et al.,
1999). Here, primary radiotherapy showed some effect on reduction
of lymph node metastasis in the left posterior triangle of neck.
The typical cytological features of PSCC were monolayered sheets of
mildly atypical glandular cells with papillary branches.We studied their
immunohistochemical proﬁle, using a panel of antibodies against CK5/6
for squamous cell carcinoma, CK7, CEA, CA12-5, P16 and P53 for adeno-
carcinoma, all of which were immunopositive and indicated as mixed
adenosquamous carcinoma (Fig. 1.). The result is consistent with a pre-
vious report that P53 and CEA immunostaining signiﬁcantly correlated
with the PSCC morphology (Nofech-Mozes et al., 2006).
PSCCs are aggressive and are usually foundwith lymphnodemetasta-
ses. Whereas, Ueda et al. reported that advanced PSCC showed a remark-
able response to paclitaxel and carboplatin combination chemotherapy
(Ueda et al., 2012), however, postoperative concurrent chemoradio-
therapy did not work well with our patient, only alive for 17 months
after surgery. This may be due to that mixed AC/ASC behaves more
aggressively than pure PSCC, which was consistent with some reportsthat AC/ASC is an independent prognostic factor for cervical cancer
patients (Huang et al., 2012).
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